Reply: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation

Affiliations

Comment

Jeong-Ju Yoo et al. Liver Transpl. 2023.

. 2023 Nov 1;29(11):E38-E39.

doi: 10.1097/LVT.0000000000000154. Epub 2023 Apr 11.

¹ Department of Internal Medicine, Gastroenterology and Hepatology, Soonchunhyang University School of Medicine, Bucheon, South Korea.

No abstract available

Comment on

Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation.
Yoo JJ, Chang JI, Moon JE, Sinn DH, Kim SG, Kim YS. Yoo JJ, et al. Liver Transpl. 2023 Oct 1;29(10):1029-1040. doi: 10.1097/LVT.0000000000000126. Epub 2023 Mar 20. Liver Transpl. 2023. PMID: 36929833
Letter to the Editor: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation.
Jia D, Guo S, Luo J, Li S. Jia D, et al. Liver Transpl. 2023 Nov 1;29(11):E36-E37. doi: 10.1097/LVT.0000000000000152. Epub 2023 Apr 11. Liver Transpl. 2023. PMID: 37036243 No abstract available.

1. Israni AK, Zaun D, Rosendale JD, Schaffhausen C, McKinney W, Snyder JJ. OPTN/SRTR 209 Annual Data Report: Deceased Organ Donors. Am J Transplant. 2021;2(suppl 2):52–558.
1. Joo DJ. Current status of deceased donor liver transplantation for alcoholic liver disease in Korea in MELD era. Korean J Gastroenterol. 2021;77:4.
1. Lee J, Lee JG, Jung I, Joo DJ, Kim SI, Kim MS, et al. Development of a Korean liver allocation system using Model For End Stage Liver Disease scores: a nationwide, multicenter study. Sci Rep. 2019;9:7495.
1. Lee JA, Choi G-s, Kim JM, Kwon CHD, Joh J-W. Comparison study of outcomes of deceased donor liver transplantation before and after Korean Model for End-Stage Liver Disease (MELD) System: single center experience. Korean J Transplant. 2018;32:7–11.
1. Kim WR, Mannalithara A, Kwo PY, Bonham CA, Kwong A. Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40. Hepatology. 2023;77:85–86.